DGAP-News: CompuGroup Medical SE

DGAP-News: CompuGroup Medical SE Third Quarter Results 2016

DGAP-News: CompuGroup Medical SE / Key word(s): Quarter Results CompuGroup Medical SE Third Quarter Results 2016

09.11.2016 / 08:00 The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

CompuGroup Medical SE Third Quarter Results 2016

Koblenz - November 9, 2016: CompuGroup Medical SE today presented the financial report for the third quarter of 2016. The company, one of the leading global providers of eHealth solutions, achieved revenue of EUR 136 million compared to EUR 126 million in the same period last year. This corresponds to 8 percent growth of which 7 percent is organic growth. The operating profit (EBITDA) reached EUR 28 million compared to EUR 21 million in the third quarter 2015. The corresponding operating margin was 21 percent compared to 17 percent in 2015.

The third quarter marked a solid rebound in the areas of pharmacy and hospital software, with both areas showing double digit year-on-year organic growth. In the pharmacy sector, the growth initiatives launched in June had a significant positive impact over the summer period and revenue from hardware, software and services rebounded strongly. In the hospital space, the main markets in Austria, Switzerland and Germany are performing well based on a good backlog of already contracted project revenue.

For the first nine months combined, revenue continues to steadily grow and reached EUR 407 million. Profitability in the nine month period is two percentage points higher than last year and drives a 13 percent increase in EBITDA up to EUR 89 million.

Frank Gotthardt, CEO and Chairman of the Board of CompuGroup Medical SE, stated: "The third quarter of 2016 has done well for our full-year goals. More importantly, we have now begun the first phase testing for the roll- out of all the technology and components we have developed for the coming German Telematics Infrastructure and from the current status, we expect to be ready to begin the nationwide roll-out in the second quarter of 2017. It will be tight but it is still our goal and it is still possible to complete the nationwide roll-out by July 2018 as is required by the eHealth law."

CompuGroup Medical reaffirms the full year 2016 guidance presented in the 2015 Annual Report. Group revenue is expected to be in the range of EUR 560 million to EUR 570 million and operating income (EBITDA) is expected to be in the range of EUR 125 million to EUR 133 million.

Conference Call for Journalists, Investors and Analysts: The management board of CompuGroup Medical SE will go through the Q3 results at a conference for analysts and investors today at 15:00 hours CEST.

You can participate in this conference call by dialing one of the following phone numbers:

+49 69 2 10 86 97 03 (Germany) +44 16 16 01 89 02 (UK) +1 21337 50479 (USA) Participant code: 18 56 12 70

A presentation will be available for download on www.cgm.com/investor- relations prior to the conference call and can also be viewed live at: www.cgm.com/onlinepresentation.

About CompuGroup Medical SE CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of more than EUR 500 million, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of approximately 400,000 doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 19 countries and products in more than 40 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 4,300 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for media representatives:

CompuGroup Medical SE Oliver Bruzek Vice President Political & Public Affairs P +49 (0) 261 8000-6100 F +49 (0) 261 8000-3100 E-mail: press@cgm.com

---------------------------------------------------------------------------

09.11.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

---------------------------------------------------------------------------

Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE0005437305 WKN: 543730 Indices: TecDax Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service ---------------------------------------------------------------------------

518771 09.11.2016